Bioengineered hierarchical bonelike compartmentalized microconstructs using nanogrooved microdiscs

Fabrication of vascularized large-scale constructs for regenerative medicine remains elusive since most strategies rely solely on cell self-organization or overly control cell positioning, failing to address nutrient diffusion limitations. We propose a modular and hierarchical tissue-engineering str...

ver descrição completa

Detalhes bibliográficos
Autor principal: Bjørge, Isabel M. (author)
Outros Autores: Sousa, Bárbara M. de (author), Patrício, Sónia G. (author), Silva, Ana Sofia (author), Nogueira, Liebert P. (author), Santos, Lúcia F. (author), Vieira, Sandra I. (author), Haugen, Håvard J. (author), Correia, Clara R. (author), Mano, João F (author)
Formato: article
Idioma:eng
Publicado em: 2023
Assuntos:
Texto completo:http://hdl.handle.net/10773/34587
País:Portugal
Oai:oai:ria.ua.pt:10773/34587
Descrição
Resumo:Fabrication of vascularized large-scale constructs for regenerative medicine remains elusive since most strategies rely solely on cell self-organization or overly control cell positioning, failing to address nutrient diffusion limitations. We propose a modular and hierarchical tissue-engineering strategy to produce bonelike tissues carrying signals to promote prevascularization. In these 3D systems, disc-shaped microcarriers featuring nanogrooved topographical cues guide cell behavior by harnessing mechanotransduction mechanisms. A sequential seeding strategy of adipose-derived stromal cells and endothelial cells is implemented within compartmentalized, liquefied-core macrocapsules in a self-organizing and dynamic system. Importantly, our system autonomously promotes osteogenesis and construct's mineralization while promoting a favorable environment for prevascular-like endothelial organization. Given its modular and self-organizing nature, our strategy may be applied for the fabrication of larger constructs with a highly controlled starting point to be used for local regeneration upon implantation or as drug-screening platforms.